TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

NCT00077142 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: TAC-101

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]